SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-048365
Filing Date
2023-04-21
Accepted
2023-04-21 16:05:15
Documents
20
Period of Report
2023-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm231992-3_def14a.htm DEF 14A 1662247
2 GRAPHIC bc_compensatio-4clr.jpg GRAPHIC 154419
3 GRAPHIC fc_election-4c.jpg GRAPHIC 59528
4 GRAPHIC fc_executive-4c.jpg GRAPHIC 188213
5 GRAPHIC fc_kpmgllp-4c.jpg GRAPHIC 110060
6 GRAPHIC fc_nonbinding-4c.jpg GRAPHIC 97039
7 GRAPHIC fc_proposal2-4c.jpg GRAPHIC 109810
8 GRAPHIC fc_sales-4c.jpg GRAPHIC 137958
9 GRAPHIC fc_stockoption-4c.jpg GRAPHIC 84966
10 GRAPHIC ic_chairfemale-bw.jpg GRAPHIC 1941
11 GRAPHIC ic_chairperson-bw.jpg GRAPHIC 2112
12 GRAPHIC ic_comp-bw.jpg GRAPHIC 8329
13 GRAPHIC ic_mail-bw.jpg GRAPHIC 9093
14 GRAPHIC ic_member-bw.jpg GRAPHIC 1891
15 GRAPHIC ic_memfemale-bw.jpg GRAPHIC 1812
16 GRAPHIC ic_telephone-bw.jpg GRAPHIC 8523
17 GRAPHIC lg_zynerbapharmaceut-4clr.jpg GRAPHIC 48665
18 GRAPHIC px_annualmeeting01-bw.jpg GRAPHIC 925611
19 GRAPHIC px_annualmeeting02-bw.jpg GRAPHIC 407003
20 GRAPHIC sg_armandoanido-bw.jpg GRAPHIC 12940
  Complete submission text file 0001104659-23-048365.txt   4628275
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37526 | Film No.: 23836325
SIC: 2834 Pharmaceutical Preparations